US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on July 21 for "Method of preventing or treating pancreatic dysfunction or diabetes by upregulating human cathelicidin LL-37 to inhibit islet amyloid polypeptide (IAPP) self-assembly" (American, German Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,490, issued on July 21, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Method of preventing or treating pancreatic dysfunction or diabetes by upregulating human cathelicidin LL-37 to inhibit islet amyloid polypeptide (IAPP) self-assembly" was invented by Valentina Armiento (Kranzberg, Germany), Annelise E. Barron (Woodside, Calif.), Aphrodite Kapurniotu (Muenich, Germany) and John A. Fortkort (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for treating type 2 diabetes (T2D) is provided. The method comprises diagnosing a subject as suffering from T2D or as being pre-diabetic;...